drugset / Trial / NCT00030342

Biological Therapy and Chemotherapy in Treating Patients With Metastatic Kidney Cancer or Colorectal Cancer

NCT00030342

Phase 1/2 Completed 60 enrolled St. Luke's Medical Center
Treatment

Summary

RATIONALE: Biological therapies use different ways to stimulate the immune system and stop cancer cells from growing. Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining biological therapy with chemotherapy may kill more tumor cells. PURPOSE: Phase I/II trial to study the effectiveness of biological therapy combined with chemotherapy in treating patients who have metastatic kidney cancer or colorectal cancer.

Timeline

Start
2001-11
Primary completion
2007-10
Completion
2008-01

Drugs

EvaluationDrugModalityDoseRoute
Subject 12ATC Cell therapy Intravenous
Subject fluorouracil Small molecule Intravenous
Subject interferon alfa-2b Protein / enzyme biologic Subcutaneous
Subject sargramostim Protein / enzyme biologic Subcutaneous